Temporal trends in treatment-related cardiopulmonary disease-specific mortality in NSCLC based on pathological subtypes: a retrospective population-based cohort study.

Ther Adv Med Oncol · 2025 · PMC12491816 · PMID 41049581

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The proportion of cardiac AEs associated with ICB agents among all cardiac AEs showed an increasing trend from 2015 to 2019 (green bars) in lung cancer ( Figure 5(a) ), with the proportion in NSCLC rising from 13.46% to 47.07% ( Figure 5(c) ) and in LADC rising from 8.24% to 32.65% ( Figure 5(e) ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.